Because of its ability to segregate the samples from the Pure DCIS group from the Not Pure DCIS group in all PCP groups, we placed CAMK2N1 at the top of the tree, separating high and low expression categories. This evidence concerns the gene CAMK2N1 and ductal breast carcinoma in situ.